NASDAQ:UPXI Upexi (UPXI) Stock Price, News & Analysis $3.18 -0.28 (-8.09%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Upexi Stock (NASDAQ:UPXI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Upexi alerts:Sign Up Key Stats Today's Range$3.18▼$3.6550-Day Range$3.46▼$5.9752-Week Range$2.17▼$33.00Volume15,748 shsAverage Volume24,660 shsMarket Capitalization$3.31 millionP/E RatioN/ADividend YieldN/APrice Target$25.00Consensus RatingHold Company OverviewUpexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.Read More… Upexi Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks49th Percentile Overall ScoreUPXI MarketRank™: Upexi scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingUpexi has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageUpexi has received no research coverage in the past 90 days.Read more about Upexi's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioUpexi has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Upexi's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.17% of the float of Upexi has been sold short.Short Interest Ratio / Days to CoverUpexi has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Upexi has recently decreased by 20.77%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUpexi does not currently pay a dividend.Dividend GrowthUpexi does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.17% of the float of Upexi has been sold short.Short Interest Ratio / Days to CoverUpexi has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Upexi has recently decreased by 20.77%, indicating that investor sentiment is improving significantly. News and Social Media0.6 / 5News SentimentN/A Search Interest3 people have searched for UPXI on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Upexi insiders have not sold or bought any company stock.Percentage Held by Insiders38.35% of the stock of Upexi is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 5.68% of the stock of Upexi is held by institutions.Read more about Upexi's insider trading history. Receive UPXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Upexi and its competitors with MarketBeat's FREE daily newsletter. Email Address UPXI Stock News HeadlinesMangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock SplitDecember 4, 2024 | markets.businessinsider.comUpexi files litigation over ‘manipulation of fractional share roundups’November 26, 2024 | markets.businessinsider.comA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. January 21, 2025 | Porter & Company (Ad)Upexi receives non-compliance notice from NasdaqNovember 23, 2024 | markets.businessinsider.comUpexi (NASDAQ:UPXI) Stock, Option ChainNovember 7, 2024 | benzinga.comUpexi trading halted, volatility trading pauseOctober 30, 2024 | markets.businessinsider.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.61%October 25, 2024 | msn.comWhat's Going On With Upexi Shares Friday?October 25, 2024 | msn.comSee More Headlines UPXI Stock Analysis - Frequently Asked Questions How have UPXI shares performed this year? Upexi's stock was trading at $3.51 at the beginning of the year. Since then, UPXI shares have decreased by 9.4% and is now trading at $3.18. View the best growth stocks for 2025 here. How were Upexi's earnings last quarter? Upexi, Inc. (NASDAQ:UPXI) announced its earnings results on Thursday, December, 19th. The company reported ($1.55) EPS for the quarter. When did Upexi's stock split? Upexi's stock reverse split on the morning of Thursday, October 3rd 2024. The 1-20 reverse split was announced on Thursday, October 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Upexi? Shares of UPXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Upexi own? Based on aggregate information from My MarketBeat watchlists, some other companies that Upexi investors own include Ford Motor (F), Meta Platforms (META), Tesla (TSLA), Walt Disney (DIS), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Devon Energy (DVN). Company Calendar Last Earnings12/19/2024Today1/21/2025Next Earnings (Estimated)2/12/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:UPXI CUSIPN/A CIK1775194 Webgroveinc.io Phone701-353-5425FaxN/AEmployees130Year FoundedN/APrice Target and Rating Average Stock Price Target$25.00 High Stock Price Target$25.00 Low Stock Price Target$25.00 Potential Upside/Downside+678.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.39 Current Ratio0.69 Quick Ratio0.53 Sales & Book Value Annual Sales$26 million Price / Sales0.13 Cash FlowN/A Price / Cash FlowN/A Book Value$6.24 per share Price / Book0.51Miscellaneous Outstanding Shares1,040,000Free Float642,000Market Cap$3.34 million OptionableOptionable Beta0.12 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:UPXI) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Upexi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Upexi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.